CVS Caremark Newswire

Comprehensive Real-Time News Feed for CVS Caremark.

Results 1 - 20 of 153 in CVS Caremark

  1. Legislative Report from the People's HouseRead the original story w/Photo

    Thursday Feb 12 | Baxley News-Banner

    ... routinely under pay community pharmacies while paying the pharmacies (Express Scripts is a PBM that owns CVS Caremark) that they own at much higher rates. HB 470 would level the playing field by requiring PBMs to be transparent in their pricing and ...

    Comment?

  2. It is hard for people to swallow pills they can't affordRead the original story w/Photo

    Monday | Kevin, M.D.

    ... at Harvard. Gagne and colleagues analyze data from Medicare patients who got their prescription benefits from CVS Caremark. They looked at whether people received prescriptions for either generic or trade statins. And they analyzed how consistently ...

    Comment?

  3. Customer Service Representative - Call Center - Open HouseRead the original story

    Monday Mar 2 | Monster.com

    ... Certifications as a pharmacy technician and/or licensure Verifiable High School diploma or GED is required CVS Caremark, through our unmatched breadth of service offerings, is transforming the delivery of health care services in the U.S. We are an ...

    Comment?

  4. Catamaran EPS Tops, But Stock Falls On Weak GuidanceRead the original story w/Photo

    Thursday Feb 26 | Investor's Business Daily

    The provider of pharmacy benefit management services saw adjusted earnings climb 19.6% to 67 cents a share in Q4, marking a second straight quarter of accelerating growth. Analysts polled by Thomson Reuters expected 61 cents.

    Comment?

  5. 5 Top Balanced Mutual Funds To Offset VolatilityRead the original story w/Photo

    Thursday Feb 26 | Seeking Alpha

    Balanced funds provide investors with the convenience of buying into a single fund rather than holding both equity and bond funds. This category of funds also reduces a portfolio's volatility while providing higher returns than pure fixed income investments.

    Comment?

  6. Narrowing ChoiceRead the original story

    Wednesday Feb 25 | The American Journal of Managed Care

    ... discussion gained momentum when Caremark was acquired by CVS. Many Caremark clients were concerned that the new CVS Caremark would preclude Walgreens from being in their retail network; CVS reassured its clients, meanwhile creating an out-of-pocket ...

    Comment?

  7. PawSox sale announcedRead the original story w/Photo

    Monday Feb 23 | CW28 Providence

    ... Boston Red Sox Frank M. Resnek - Partner, Boston Red Sox Thomas M. Ryan - Former Chairman, President and CEO, CVS Caremark The Triple-A -A International League, The National Association of Minor League Baseball and Major League Baseball have all ...

    Comment?

  8. PawSox purchased by group of New England business leadersRead the original story w/Photo

    Monday Feb 23 | WLNE-TV Providence

    ... Fleet National Bank Arthur E. Nicholas - Partner, Red Sox Thomas M. Ryan - Former Chairman, President and CEO, CVS Caremark The Triple-A International League, The National Association of Minor League Baseball and Major League Baseball have all ...

    Comment?

  9. Consumer Concerns: With purchase of EnvisionRx, Rite Aid gets in on the drug intermediary racketRead the original story w/Photo

    Friday Feb 20 | The Fresno Bee

    ... the industry, Express Scripts, handles prescriptions for about 90 million Americans. The second-largest player, CVS Caremark, covers about 65 million people. But even that relatively low number is worth $2 billion to the drugstore chain, ...

    Comment?

  10. With purchase of EnvisionRx, Rite Aid gets in on the drug intermediary racketRead the original story

    Thursday Feb 12 | Los Angeles Times

    ... the industry, Express Scripts, handles prescriptions for about 90 million Americans. The second-largest player, CVS Caremark, covers about 65 million people. But even that relatively low number is worth $2 billion to the drugstore chain, ...

    Comment?

  11. Rite Aid buys EnvisionRX, enters pharmacy benefit businessRead the original story w/Photo

    Wednesday Feb 11 | Bangor Daily News

    Drugstore operator Rite Aid Corp. agreed to buy pharmacy benefit manager EnvisionRx for about $2 billion, looking to cut drug procurement costs as reimbursement rates fall. The third-largest U.S. drug-store operator's shares jumped as much as 12 percent Wednesday in heavy trading.

    Comment?

  12. Rite Aid To Buy Pharmacy Benefits Manager EnvisionRXRead the original story w/Photo

    Wednesday Feb 11 | Investor's Business Daily

    The drugstore chain said it would purchase the privately held company, currently owned by the investment firm TPG, for $1.8 billion in cash and $200 million in stock. "With the addition of EnvisionRx, we will create a compelling pharmacy offering across retail, specialty and mail-order channels, enabling us to deliver cost-effective solutions to employers and health plans while driving growth and creating long-term value for our shareholders," Rite Aid CEO John Standley said in the release.

    Comment?

  13. Specialty drugs help CVS Health meet 4Q profit forecastsRead the original story

    Tuesday Feb 10 | ETaiwanNews.com

    ... sales from its stores, a move the chain completed by September, when it also changed its corporate name from CVS Caremark. The company said last fall that the move would cut earnings by between 7 cents and 8 cents per share. CVS executives said ...

    Comment?

  14. Specialty drugs help CVS Health meet profit forecastsRead the original story w/Photo

    Tuesday Feb 10 | Worcester Telegram & Gazette

    ... The company's stores kicked those sales by late September, when the corporate name changed to CVS Health from CVS Caremark. The move drew praise from President Barack Obama, an ex-smoker, and it earned CEO Larry Merlo an invitation to watch the ...

    Comment?

  15. Stock Futures Stretch Higher; Starwood, Coca-Cola, CVS ClimbRead the original story w/Photo

    Tuesday Feb 10 | Investor's Business Daily

    Dow futures lofted 122.8 points above fair market value. Nasdaq 100 futures climbed 28.7 points, while S&P 500 futures were ahead 14.5 points.

    Comment?

  16. Specialty Drugs Help CVS Health Meet Fourth Quarter Profit ForecastsRead the original story w/Photo

    Tuesday Feb 10 | Pharmaceutical Processing

    ... The company's stores kicked those sales by late September, when the corporate name changed to CVS Health from CVS Caremark. The move drew praise from President Barack Obama, an ex-smoker, and it earned CEO Larry Merlo an invitation to watch the ...

    Comment?

  17. CVS Health Earnings Rise on Retail Pharmacy GainsRead the original story w/Photo

    Tuesday Feb 10 | Wall Street Journal

    ... eclines in retail sales because of the lack of cigarette sales. The company changed its name to CVS Health from CVS Caremark last year as it ended sales of tobacco products.

    Comment?

  18. Customer Service SpecialistRead the original story

    Monday Feb 9 | One Nation News

    ... national provider of specialty home infusion and specialty pharmacy services. The integration of Coram into CVS Caremark enables the company to offer enhanced, comprehensive infusion services; expanded payer access; and a national network of more ...

    Comment?

  19. InvestorsObserver releases comments on Coca-Cola, CVS Corp.,...Read the original story

    Monday Feb 9 | Sys-Con Media

    To see what our analysts have discovered about these stocks read the InvestorsObserver's Stocks To Watch guide at . The following stocks are featured in the Stocks To Watch guide: Coca-Cola , CVS Corp. , Occidental Petroleum , Advance Auto Parts , and InvestorsObserver's Stocks To Watch guide provides investors with critical information on stocks that may be poised for a significant move.

    Comment?

  20. Will CVS Report Healthy Growth In Q4 EPS And Sales?Read the original story w/Photo

    Friday Feb 6 | Investor's Business Daily

    Analysts polled by Thomson Reuters expect the drugstore chain to grow earnings per share by 7.1% to $1.20. Revenue is projected to jump 9.8% to $36.06 billion.

    Comment?